Miss Rate of Gastric Neoplasms Under Computer-aided Endoscopy

Recruiting now · Not applicable

Conditions studied: Gastric Neoplasm, Artificial Intelligence

In brief

This prospective randomized trial compares AI-assisted upper gastrointestinal endoscopy with high definition upper gastrointestinal endoscopy in term of missed rate of gastric neoplasm. The investigators hypothesize the miss rate of high definition upper gastrointestinal endoscopy is higher than AI-assisted upper gastrointestinal endoscopy.

Key facts

Study ID

NCT06495645

Run by

The University of Hong Kong

People needed

1000

Starts

2024-11-01

Expected to finish

2026-12-31

Last updated by the study team

2025-11-20

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged 40 or older
• Scheduled for elective upper endoscopy

You may not qualify if…

• Pregnant women,
• Inability to provide written informed consent
• Prior gastrectomy, and
• Patients deemed unsuitable or high-risk for endoscopy with severe comorbid illnesses

Where it is running

• Queen Mary Hospital, the University of Hong Kong — Hong Kong, Hong Kong (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.